Dachaigh › Aillse Prostata › Michigan
Sgrùdaidhean clionaigeach Aillse Prostata ann an Michigan
Tha 57 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann an Michigan.
Bailtean ann an Michigan
- Ann Arbor27 sgrùdaidhean
- Detroit22 sgrùdaidhean
- Grand Rapids19 sgrùdaidhean
- Lansing10 sgrùdaidhean
- Farmington Hills8 sgrùdaidhean
- Clinton Township8 sgrùdaidhean
- Canton8 sgrùdaidhean
- Warren7 sgrùdaidhean
- Livonia7 sgrùdaidhean
- Flint7 sgrùdaidhean
- Waterford7 sgrùdaidhean
- Dearborn6 sgrùdaidhean
- Troy5 sgrùdaidhean
- Saginaw5 sgrùdaidhean
- Jackson4 sgrùdaidhean
- Wyoming4 sgrùdaidhean
- Kalamazoo3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- agus 13 a bharrachd
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06995898A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Cancer And Hematology Centers Of Western Michigan, Holland
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 5 Dàmh 2026 · NCT07723248A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- agus 8 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Dàmh 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Henry Ford Cancer Institute-Downriver, Brownstown
- agus 17 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Dàmh 2026 · NCT07200830Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06632977Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- agus 68 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health Medical Center - Brighton, Brighton
- agus 32 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT03866382Precision-Based Genomics in Prostate Cancer
- University of Michigan, Ann Arbor
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Fir · Air ùrachadh 28 Sult 2026 · NCT04706663Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- South Texas Accelerated Research Therapeutics, LLC (START), Grand Rapids
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Sult 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Henry Ford Hospital ( Site 0015), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0005), Grand Rapids
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06136650Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Ann Arbor
- Research Site, Detroit
A’ fastadhÌre 1/2
Aoisean 18 gu 130 · Fir · Air ùrachadh 25 Sult 2026 · NCT07181161A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
- Start Midwest, Grand Rapids
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 25 Sult 2026 · NCT07746713This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Michigan Institute of Urology, PC, Troy
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Sult 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Midwest, Grand Rapids
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Sult 2026 · NCT07719361A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Barbara Ann Karmanos Cancer Institute, Detroit
- BAMF Health Inc., Grand Rapids
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07114601A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Barbara Ann Karmanos Cancer Institute, Lansing
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 22 Sult 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Karmanos Cancer Institute, Detroit
A’ fastadhÌre 3
Aoisean 18 gu 100 · Fir · Air ùrachadh 22 Sult 2026 · NCT06855277Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])
- BAMF Health, Grand Rapids
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 21 Sult 2026 · NCT07831824Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University of Michigan ( Site 0005), Ann Arbor
- Henry Ford Hospital ( Site 0035), Detroit
- Cancer and Hematology Centers of Western Michigan ( Site 0015), Grand Rapids
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Sult 2026 · NCT06925737First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- GSK Investigational Site, Grand Rapids
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 16 Sult 2026 · NCT07332455A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- BAMF Health, Grand Rapids
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 15 Sult 2026 · NCT07581184Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Wayne State University, Detroit
A’ fastadh
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Sult 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- BAMF Health, Grand Rapids
- Corewell Health, Grand Rapids
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 11 Sult 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health Medical Center - Brighton, Brighton
- agus 21 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 10 Sult 2026 · NCT05946213Prostate Active Surveillance Study
- University of Michigan, Ann Arbor
A’ fastadhSgrùdadh amharc
Aoisean 21 agus nas sine · Fir · Air ùrachadh 2 Sult 2026 · NCT00756665A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Research Site, Grand Rapids
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 2 Sult 2026 · NCT07192614COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Rogel Cancer Center, Ann Arbor
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Fir · Air ùrachadh 27 Lùna 2026 · NCT07050433AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Grand Rapids
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 26 Lùna 2026 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Henry Ford, Novi
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 24 Lùna 2026 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Karmanos Cancer Institute, Detroit
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 20 Lùna 2026 · NCT06785636EDRN Prostate MRI Biomarker Study
- University of Michigan, Ann Arbor
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Lùna 2026 · NCT03784924Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- University of Michigan Health, Ann Arbor
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Lùna 2026 · NCT04812366SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
- University of Michigan Comprehensive Cancer Center, Ann Arbor
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Fir · Air ùrachadh 27 Iuch 2026 · NCT07096999Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- McLaren Cancer Institute-Bay City, Bay City
- agus 19 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Fir · Air ùrachadh 14 Iuch 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Karmanos, Detroit
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Fir · Air ùrachadh 9 Iuch 2026 · NCT05413421Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
- Karmanos Cancer Institute, Detroit
A’ fastadh
Aoisean 20 gu 79 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07436078Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- McLaren Proton Therapy Center, Flint
A’ fastadh
Aoisean 18 agus nas sine · Fir · Air ùrachadh 17 Ògmh 2026 · NCT00969111Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Ann Arbor Healthcare System, Ann Arbor
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Fir · Air ùrachadh 15 Ògmh 2026 · NCT05422911Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.